FDA Brings Down Hammer on CBD Companies

The Food and Drug Administration is cracking down on several companies selling products advertised as containing cannabidiol (CBD), a compound in marijuana widely used without FDA approval to treat epilepsy and other conditions – and some medical pot activists are pleased to hear it.

In late February, the federal agency sent letters to seven companies that market CBD products to treat health conditions, five of them for humans and two for pets, warning their products are not “generally recognized as safe and effective“ and that the companies are engaging in illegal interstate commerce.

Marijuana is a Schedule I drug under the Controlled Substances Act, which means under federal law it has no accepted medical value. CBD, however, does not produce a high and research into the compound is on the upswing as parents of epileptic children and others flee to states that allow its use.

Although now accessible in most...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.